Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Galera Therapeutics, Inc. (GRTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4400+0.1700 (+5.20%)
At close: 04:00PM EST
3.4500 +0.01 (+0.29%)
After hours: 07:08PM EST
Advertisement
Sign in to post a message.
  • S
    Sam Max Bet
    Setting the stage for a big move to $20. Hop on before it’s too late.
    Bullish
  • B
    BPL001
    I don't believe that all of these Analysts are wrong on their Price Target. This stock should be at least $10/share. Good Luck Longs.

    Citigroup upgraded to BUY @ $20/share
    BTIG upgraded to BUY @ $15/share
    HC Wainwright& Co upgraded to BUY @ $10/share
    Bullish
  • U
    Uwe
    today Fintel is reporting GRTX as the number 1 stock for a short squeeze out of 5,416. It’s been in top 10 last few weeks but first time it’s made it to #1.
  • C
    Chiron
    The arguing of bashers here is so weak and irrelevant that they don't even deserve a thumbs down!
    The run-up to 15+ in less than 6 months is unstoppable. This stock has already shown solid evidence that their drug works and that's why the FDA awarded it Breakthrough Therapy and Fast Track designations.

    Keep in mind that drugs with a BTD are typically approved about 3 months before their PDUFA target compared to those without that designation...so if the company submits its NDA this quarter, Avasopasem could be FDA approved in less than 6 months.
    Bullish
  • B
    BPL001
    hold on your shares. MM is trying to play with you. This stock will $10/share soon.
  • y
    yusuf
    I really dont know if we'll close green today, but I'm sure that we will smile in first quarter of 2022. Have a nice holiday.
  • B
    BPL001
    Here are 3 analysts rated this stock in December 2021.

    Citigroup upgraded to BUY @ $20/share
    BTIG upgraded to BUY @ $15/share
    HC Wainwright& Co upgraded to BUY @ $10/share
    Bullish
  • B
    BPL001
    Longs - GRTX has 2 drugs going on for the first half of 2022.

    1. Phase 3 ROMAN was successful and will review with FDA on Q1 for approval.

    2. GRECO-2 trials is currently on the way and will report initial data on first half of 2022.

    Based on these drugs, this stock will be $20/share easy in 2022.
  • J
    Joe Byron
    3.88 close ??
  • T
    TheRag
    Not sure who and why anyone wd sell under $12/share. That's just the base value here now with the corrected data.
  • A
    Agon Alea
    good week... almost 70% up... not yet done.
    Bullish
  • M
    Marcus
    IMO.. buy stock and not options in this. With such a low float, if you buy the stock and hold, it will short squeeze the short and also make less shares available to short. If you just buying options, you are relying on the rest of us to spend our resources to drive the price up so that you can get in the money while you are spending your resources on options. Buying options won't move the price unless other push the stock price into the money to force the broker to buy the stock. If everyone just bought the option, the stock price wouldn't move and we all lose our money...
  • I
    Ivan
    ok institutions...we are over $5.00. time to start buying GRTX shares. now at a discount!!!
  • s
    samir
    ready for launch any time now.
    Bullish
  • A
    Agon Alea
    looks ominous. I am sitting on a profit but still worrisome
  • B
    Brian
    AH manipulation at it’s finest by shorts dropping PPS to scare holders…I’m waiting for Thursday to buy more..currently holding 16,650..don’t get fooled here
  • j
    jimmy
    Should I buy more or sell for a profit while I have one .?
  • h
    hassan
    Put your sell at 15 $$$
  • C
    Crazy Horse
    I'm in for 1000 shares.
    Bullish
  • t
    thunderup40
    $5.25 by EOD?
Advertisement
Advertisement